530 related articles for article (PubMed ID: 23222956)
1. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Piazza R; Valletta S; Winkelmann N; Redaelli S; Spinelli R; Pirola A; Antolini L; Mologni L; Donadoni C; Papaemmanuil E; Schnittger S; Kim DW; Boultwood J; Rossi F; Gaipa G; De Martini GP; di Celle PF; Jang HG; Fantin V; Bignell GR; Magistroni V; Haferlach T; Pogliani EM; Campbell PJ; Chase AJ; Tapper WJ; Cross NC; Gambacorti-Passerini C
Nat Genet; 2013 Jan; 45(1):18-24. PubMed ID: 23222956
[TBL] [Abstract][Full Text] [Related]
2. Somatic SETBP1 mutations in myeloid neoplasms.
Makishima H
Int J Hematol; 2017 Jun; 105(6):732-742. PubMed ID: 28447248
[TBL] [Abstract][Full Text] [Related]
3. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Meggendorfer M; Bacher U; Alpermann T; Haferlach C; Kern W; Gambacorti-Passerini C; Haferlach T; Schnittger S
Leukemia; 2013 Sep; 27(9):1852-60. PubMed ID: 23628959
[TBL] [Abstract][Full Text] [Related]
4. Somatic SETBP1 mutations in myeloid malignancies.
Makishima H; Yoshida K; Nguyen N; Przychodzen B; Sanada M; Okuno Y; Ng KP; Gudmundsson KO; Vishwakarma BA; Jerez A; Gomez-Segui I; Takahashi M; Shiraishi Y; Nagata Y; Guinta K; Mori H; Sekeres MA; Chiba K; Tanaka H; Muramatsu H; Sakaguchi H; Paquette RL; McDevitt MA; Kojima S; Saunthararajah Y; Miyano S; Shih LY; Du Y; Ogawa S; Maciejewski JP
Nat Genet; 2013 Aug; 45(8):942-6. PubMed ID: 23832012
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
Wang L; Du F; Zhang HM; Wang HX
Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341
[TBL] [Abstract][Full Text] [Related]
6. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract][Full Text] [Related]
8. TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
Qiao HY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Yan J; Li C; Wang HQ
Cancer Lett; 2022 Mar; 529():85-99. PubMed ID: 34973391
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.
Torrejón B; Cristóbal I; Caramés C; Prieto-Potín I; Chamizo C; Santos A; Sanz-Alvarez M; Serna-Blasco R; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
World J Surg; 2018 Nov; 42(11):3771-3778. PubMed ID: 29796729
[TBL] [Abstract][Full Text] [Related]
10. SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.
Piazza R; Magistroni V; Redaelli S; Mauri M; Massimino L; Sessa A; Peronaci M; Lalowski M; Soliymani R; Mezzatesta C; Pirola A; Banfi F; Rubio A; Rea D; Stagno F; Usala E; Martino B; Campiotti L; Merli M; Passamonti F; Onida F; Morotti A; Pavesi F; Bregni M; Broccoli V; Baumann M; Gambacorti-Passerini C
Nat Commun; 2018 Jun; 9(1):2192. PubMed ID: 29875417
[TBL] [Abstract][Full Text] [Related]
11. Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.
Acuna-Hidalgo R; Deriziotis P; Steehouwer M; Gilissen C; Graham SA; van Dam S; Hoover-Fong J; Telegrafi AB; Destree A; Smigiel R; Lambie LA; Kayserili H; Altunoglu U; Lapi E; Uzielli ML; Aracena M; Nur BG; Mihci E; Moreira LM; Borges Ferreira V; Horovitz DD; da Rocha KM; Jezela-Stanek A; Brooks AS; Reutter H; Cohen JS; Fatemi A; Smitka M; Grebe TA; Di Donato N; Deshpande C; Vandersteen A; Marques Lourenço C; Dufke A; Rossier E; Andre G; Baumer A; Spencer C; McGaughran J; Franke L; Veltman JA; De Vries BB; Schinzel A; Fisher SE; Hoischen A; van Bon BW
PLoS Genet; 2017 Mar; 13(3):e1006683. PubMed ID: 28346496
[TBL] [Abstract][Full Text] [Related]
12. The recurrent SETBP1 c.2608G > A, p.(Gly870Ser) variant in a patient with Schinzel-Giedion syndrome: an illustrative case of the utility of whole exome sequencing in a critically ill neonate.
Leone MP; Palumbo P; Palumbo O; Di Muro E; Chetta M; Laforgia N; Resta N; Stella A; Castellana S; Mazza T; Castori M; Carella M; Bukvic N
Ital J Pediatr; 2020 May; 46(1):74. PubMed ID: 32460883
[TBL] [Abstract][Full Text] [Related]
13. Current and evolving understanding of atypical chronic myeloid leukemia.
Schwartz LC; Mascarenhas J
Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
[TBL] [Abstract][Full Text] [Related]
14. What's different about atypical CML and chronic neutrophilic leukemia?
Dao KH; Tyner JW
Hematology Am Soc Hematol Educ Program; 2015; 2015():264-71. PubMed ID: 26637732
[TBL] [Abstract][Full Text] [Related]
15. Atypical chronic myeloid leukemia: a rare entity with management challenges.
Dhakal P; Gundabolu K; Amador C; Rayamajhi S; Bhatt VR
Future Oncol; 2018 Jan; 14(2):177-185. PubMed ID: 29226717
[TBL] [Abstract][Full Text] [Related]
16. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
Inoue D; Kitaura J; Matsui H; Hou HA; Chou WC; Nagamachi A; Kawabata KC; Togami K; Nagase R; Horikawa S; Saika M; Micol JB; Hayashi Y; Harada Y; Harada H; Inaba T; Tien HF; Abdel-Wahab O; Kitamura T
Leukemia; 2015 Apr; 29(4):847-57. PubMed ID: 25306901
[TBL] [Abstract][Full Text] [Related]
17. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Gambacorti-Passerini CB; Donadoni C; Parmiani A; Pirola A; Redaelli S; Signore G; Piazza V; Malcovati L; Fontana D; Spinelli R; Magistroni V; Gaipa G; Peronaci M; Morotti A; Panuzzo C; Saglio G; Usala E; Kim DW; Rea D; Zervakis K; Viniou N; Symeonidis A; Becker H; Boultwood J; Campiotti L; Carrabba M; Elli E; Bignell GR; Papaemmanuil E; Campbell PJ; Cazzola M; Piazza R
Blood; 2015 Jan; 125(3):499-503. PubMed ID: 25343957
[TBL] [Abstract][Full Text] [Related]
18. Genomics of chronic neutrophilic leukemia.
Maxson JE; Tyner JW
Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.
Agarwal A; MacKenzie RJ; Pippa R; Eide CA; Oddo J; Tyner JW; Sears R; Vitek MP; Odero MD; Christensen DJ; Druker BJ
Clin Cancer Res; 2014 Apr; 20(8):2092-103. PubMed ID: 24436473
[TBL] [Abstract][Full Text] [Related]
20. Long term follow up of two independent patients with Schinzel-Giedion carrying SETBP1 mutations.
Herenger Y; Stoetzel C; Schaefer E; Scheidecker S; Manière MC; Pelletier V; Alembik Y; Christmann D; Clavert JM; Terzic J; Fischbach M; De Saint Martin A; Dollfus H
Eur J Med Genet; 2015 Sep; 58(9):479-87. PubMed ID: 26188272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
